Maze Therapeutics (NASDAQ:MAZE) Stock Price Up 5.6% - Still a Buy?

Shares of Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) traded up 5.6% on Tuesday . The stock traded as high as $11.98 and last traded at $11.43. 44,124 shares were traded during trading, a decline of 87% from the average session volume of 339,422 shares. The stock had previously closed at $10.82.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Leerink Partnrs raised shares of Maze Therapeutics to a "strong-buy" rating in a research report on Tuesday. Guggenheim initiated coverage on shares of Maze Therapeutics in a report on Tuesday. They issued a "buy" rating and a $19.00 price objective for the company. JPMorgan Chase & Co. started coverage on shares of Maze Therapeutics in a research report on Tuesday. They set an "overweight" rating and a $30.00 target price on the stock. TD Cowen upgraded shares of Maze Therapeutics to a "strong-buy" rating in a research report on Tuesday. Finally, Leerink Partners assumed coverage on Maze Therapeutics in a research report on Tuesday. They set an "outperform" rating and a $28.00 price target on the stock. Three investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Maze Therapeutics currently has an average rating of "Buy" and an average price target of $25.67.

Maze Therapeutics Price Performance

About Maze Therapeutics

We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. We are advancing a pipeline using our Compass platform, which allows us to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process we refer to as variant functionalization.